ID   B3GA1_RAT               Reviewed;         334 AA.
AC   O35789; A0A0H2UHF1;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   29-MAY-2024, entry version 164.
DE   RecName: Full=Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 {ECO:0000250|UniProtKB:Q9P2W7};
DE            EC=2.4.1.135 {ECO:0000269|PubMed:19181664};
DE   AltName: Full=Beta-1,3-glucuronyltransferase 1;
DE   AltName: Full=Glucuronosyltransferase P;
DE            Short=GlcAT-P {ECO:0000303|PubMed:19181664};
DE   AltName: Full=UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase;
DE            Short=GlcUAT-P;
GN   Name=B3gat1 {ECO:0000312|RGD:70880};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 62-95;
RP   185-209; 214-231; 238-262; 269-274; 280-289 AND 307-333.
RC   TISSUE=Brain;
RX   PubMed=9177175; DOI=10.1073/pnas.94.12.6093;
RA   Terayama K., Oka S., Seiki T., Miki Y., Nakamura A., Kozutsumi Y.,
RA   Takio K., Kawasaki T.;
RT   "Cloning and functional expression of a novel glucuronyltransferase
RT   involved in the biosynthesis of the carbohydrate epitope HNK-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:6093-6098(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, SUBCELLULAR
RP   LOCATION, CATALYTIC ACTIVITY, ALTERNATIVE SPLICING (ISOFORMS 1 AND 2),
RP   PROTEOLYTIC CLEAVAGE, MUTAGENESIS OF 3-LYS--ARG-5, REGION, AND INTERACTION
RP   WITH SAR1A.
RX   PubMed=19181664; DOI=10.1074/jbc.m807517200;
RA   Kizuka Y., Tonoyama Y., Oka S.;
RT   "Distinct transport and intracellular activities of two GlcAT-P isoforms.";
RL   J. Biol. Chem. 284:9247-9256(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, SUBUNIT, AND CHARACTERIZATION.
RC   TISSUE=Fetal brain;
RX   PubMed=9804790; DOI=10.1074/jbc.273.46.30295;
RA   Terayama K., Seiki T., Nakamura A., Matsumori K., Ohta S., Oka S.,
RA   Sugita M., Kawasaki T.;
RT   "Purification and characterization of a glucuronyltransferase involved in
RT   the biosynthesis of the HNK-1 epitope on glycoproteins from rat brain.";
RL   J. Biol. Chem. 273:30295-30300(1998).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-103 AND THR-108, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
CC   -!- FUNCTION: Involved in the biosynthesis of L2/HNK-1 carbohydrate epitope
CC       on glycoproteins. Can also play a role in glycosaminoglycan
CC       biosynthesis. Substrates include asialo-orosomucoid (ASOR), asialo-
CC       fetuin, and asialo-neural cell adhesion molecule. Requires
CC       sphingomyelin for activity: stearoyl-sphingomyelin was the most
CC       effective, followed by palmitoyl-sphingomyelin and lignoceroyl-
CC       sphingomyelin. Activity was demonstrated only for sphingomyelin with a
CC       saturated fatty acid and not for that with an unsaturated fatty acid,
CC       regardless of the length of the acyl group.
CC       {ECO:0000269|PubMed:19181664, ECO:0000269|PubMed:9804790}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-O-(beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-
CC         xylosyl)-L-seryl-[protein] + UDP-alpha-D-glucuronate = 3-O-(beta-D-
CC         GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-seryl-
CC         [protein] + H(+) + UDP; Xref=Rhea:RHEA:24168, Rhea:RHEA-COMP:12571,
CC         Rhea:RHEA-COMP:12573, ChEBI:CHEBI:15378, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:132090, ChEBI:CHEBI:132093;
CC         EC=2.4.1.135; Evidence={ECO:0000269|PubMed:19181664,
CC         ECO:0000269|PubMed:9804790};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:9804790};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Homodimer (PubMed:9804790). Interacts with SAR1A
CC       (PubMed:19181664). {ECO:0000269|PubMed:19181664,
CC       ECO:0000269|PubMed:9804790}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:19181664}; Single-pass type II membrane protein.
CC       Secreted {ECO:0000269|PubMed:19181664}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:19181664}; Single-pass type II membrane protein.
CC       Endoplasmic reticulum membrane {ECO:0000269|PubMed:19181664}. Secreted
CC       {ECO:0000269|PubMed:19181664}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=sGlcAT-P {ECO:0000303|PubMed:19181664};
CC         IsoId=O35789-1; Sequence=Displayed;
CC       Name=2; Synonyms=lGlcAT-P {ECO:0000303|PubMed:19181664};
CC         IsoId=O35789-2; Sequence=VSP_058540;
CC   -!- TISSUE SPECIFICITY: Brain. Greater expression found in the cerebral
CC       cortex than the cerebellum.
CC   -!- PTM: The soluble form derives from the membrane form by proteolytic
CC       processing. {ECO:0000269|PubMed:19181664}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 43 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA20551.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D88035; BAA20551.1; ALT_INIT; mRNA.
DR   EMBL; AABR07069533; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH474007; EDL83354.1; -; Genomic_DNA.
DR   EMBL; CH474007; EDL83353.1; -; Genomic_DNA.
DR   EMBL; CH474007; EDL83351.1; -; Genomic_DNA.
DR   RefSeq; NP_446455.1; NM_054003.1. [O35789-2]
DR   RefSeq; XP_006242795.1; XM_006242733.3.
DR   RefSeq; XP_006242796.1; XM_006242734.3. [O35789-1]
DR   AlphaFoldDB; O35789; -.
DR   SMR; O35789; -.
DR   STRING; 10116.ENSRNOP00000009825; -.
DR   CAZy; GT43; Glycosyltransferase Family 43.
DR   GlyCosmos; O35789; 3 sites, No reported glycans.
DR   GlyGen; O35789; 3 sites.
DR   iPTMnet; O35789; -.
DR   PhosphoSitePlus; O35789; -.
DR   PaxDb; 10116-ENSRNOP00000009825; -.
DR   Ensembl; ENSRNOT00000009825.6; ENSRNOP00000009825.5; ENSRNOG00000007142.8. [O35789-2]
DR   GeneID; 117108; -.
DR   KEGG; rno:117108; -.
DR   UCSC; RGD:70880; rat. [O35789-1]
DR   AGR; RGD:70880; -.
DR   CTD; 27087; -.
DR   RGD; 70880; B3gat1.
DR   VEuPathDB; HostDB:ENSRNOG00000007142; -.
DR   eggNOG; KOG1476; Eukaryota.
DR   GeneTree; ENSGT00940000157165; -.
DR   HOGENOM; CLU_045177_1_0_1; -.
DR   InParanoid; O35789; -.
DR   OMA; DSREYCM; -.
DR   OrthoDB; 5321308at2759; -.
DR   TreeFam; TF313522; -.
DR   Reactome; R-RNO-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   UniPathway; UPA00378; -.
DR   PRO; PR:O35789; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Proteomes; UP000234681; Chromosome 8.
DR   Bgee; ENSRNOG00000007142; Expressed in frontal cortex and 5 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005796; C:Golgi lumen; TAS:RGD.
DR   GO; GO:0000139; C:Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0015018; F:galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IBA:GO_Central.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0050650; P:chondroitin sulfate proteoglycan biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; ISO:RGD.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   GO; GO:0008542; P:visual learning; ISO:RGD.
DR   CDD; cd00218; GlcAT-I; 1.
DR   InterPro; IPR005027; Glyco_trans_43.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR10896:SF21; GALACTOSYLGALACTOSYLXYLOSYLPROTEIN 3-BETA-GLUCURONOSYLTRANSFERASE 1; 1.
DR   PANTHER; PTHR10896; GALACTOSYLGALACTOSYLXYLOSYLPROTEIN 3-BETA-GLUCURONOSYLTRANSFERASE BETA-1,3-GLUCURONYLTRANSFERASE; 1.
DR   Pfam; PF03360; Glyco_transf_43; 1.
DR   SUPFAM; SSF53448; Nucleotide-diphospho-sugar transferases; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Direct protein sequencing; Endoplasmic reticulum;
KW   Glycoprotein; Golgi apparatus; Manganese; Membrane; Metal-binding;
KW   Phosphoprotein; Reference proteome; Secreted; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..334
FT                   /note="Galactosylgalactosylxylosylprotein 3-beta-
FT                   glucuronosyltransferase 1"
FT                   /id="PRO_0000195170"
FT   TOPO_DOM        1..6
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        7..27
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        28..334
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   REGION          3..5
FT                   /note="Essential for transport from endoplasmic reticulum
FT                   to Golgi apparatus and interaction with SAR1A"
FT                   /evidence="ECO:0000269|PubMed:19181664"
FT   REGION          245..254
FT                   /note="Interaction with galactose moiety of substrate
FT                   glycoprotein"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        284
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         91..93
FT                   /ligand="UDP-alpha-D-glucuronate"
FT                   /ligand_id="ChEBI:CHEBI:58052"
FT                   /evidence="ECO:0000250"
FT   BINDING         122
FT                   /ligand="UDP-alpha-D-glucuronate"
FT                   /ligand_id="ChEBI:CHEBI:58052"
FT                   /evidence="ECO:0000250"
FT   BINDING         165
FT                   /ligand="UDP-alpha-D-glucuronate"
FT                   /ligand_id="ChEBI:CHEBI:58052"
FT                   /evidence="ECO:0000250"
FT   BINDING         170
FT                   /ligand="UDP-alpha-D-glucuronate"
FT                   /ligand_id="ChEBI:CHEBI:58052"
FT                   /evidence="ECO:0000250"
FT   BINDING         195..197
FT                   /ligand="UDP-alpha-D-glucuronate"
FT                   /ligand_id="ChEBI:CHEBI:58052"
FT                   /evidence="ECO:0000250"
FT   BINDING         197
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         311..313
FT                   /ligand="UDP-alpha-D-glucuronate"
FT                   /ligand_id="ChEBI:CHEBI:58052"
FT                   /evidence="ECO:0000250"
FT   SITE            228
FT                   /note="Interaction with galactose moiety of substrate
FT                   glycoprotein"
FT                   /evidence="ECO:0000250"
FT   SITE            321
FT                   /note="Interaction with galactose moiety of substrate
FT                   glycoprotein"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         103
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         108
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   CARBOHYD        140
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        303
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1
FT                   /note="M -> MGNEELWAQPALEM (in isoform 2)"
FT                   /id="VSP_058540"
FT   MUTAGEN         3..5
FT                   /note="KRR->AAA: Significantly disrupts Golgi apparatus
FT                   localization. Decreases galactosylgalactosylxylosylprotein
FT                   3-beta-glucuronosyltransferase activity. Impairs secretion
FT                   and interaction with SAR1A."
FT                   /evidence="ECO:0000269|PubMed:19181664"
SQ   SEQUENCE   334 AA;  38237 MW;  2C9AD8A19AA11379 CRC64;
     MPKRRDILAI VLIVLPWTLL ITVWHQSSLA PLLAVHKDEG SDPRHEAPPG ADPREYCMSD
     RDIVEVVRTE YVYTRPPPWS DTLPTIHVVT PTYSRPVQKA ELTRMANTLL HVPNLHWLVV
     EDAPRRTPLT ARLLRDTGLN YTHLHVETPR NYKLRGDARD PRIPRGTMQR NLALRWLRET
     FPRNSTQPGV VYFADDDNTY SLELFEEMRS TRRVSVWPVA FVGGLRYEAP RVNGAGKVVG
     WKTVFDPHRP FAIDMAGFAV NLRLILQRSQ AYFKLRGVKG GYQESSLLRE LVTLNDLEPK
     AANCTKILVW HTRTEKPVLV NEGKKGFTDP SVEI
//
